Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lupi

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
International Journal of Cardiology|July 22, 2023
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significanceLaura De Michieli, Monica De Gaspari, Giulio Sinigiani, et al.
JACC. Cardiovascular Interventions|August 17, 2023
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary SyndromeAntonio Landi, Mauro Chiarito, Mattia Branca, et al.
Minerva Cardiology and Angiology|February 27, 2023
OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCTMario Iannaccone, Ovidio DE Filippo, Andrea Montabone, et al.
Circulation. Heart Failure|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid CardiomyopathyLaura De Michieli, Giulio Sinigiani, Gianluigi Guida, et al.
BMJ (Clinical Research Ed.)|September 29, 2016
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trialSergio Leonardi, Enrico Frigoli, Martina Rothenbühler, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access TrialGiuseppe Gargiulo, Sara Ariotti, Pascal Vranckx, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Trials|November 25, 2020
Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trialGiuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, et al.
Journal of the American College of Cardiology|March 17, 2018
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesGiuseppe Gargiulo, Greta Carrara, Enrico Frigoli, et al.
The New England Journal of Medicine|September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Cardiology|July 22, 2023
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significanceLaura De Michieli, Monica De Gaspari, Giulio Sinigiani, et al.
JACC. Cardiovascular Interventions|August 17, 2023
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary SyndromeAntonio Landi, Mauro Chiarito, Mattia Branca, et al.
Minerva Cardiology and Angiology|February 27, 2023
OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCTMario Iannaccone, Ovidio DE Filippo, Andrea Montabone, et al.
Circulation. Heart Failure|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid CardiomyopathyLaura De Michieli, Giulio Sinigiani, Gianluigi Guida, et al.
BMJ (Clinical Research Ed.)|September 29, 2016
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trialSergio Leonardi, Enrico Frigoli, Martina Rothenbühler, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access TrialGiuseppe Gargiulo, Sara Ariotti, Pascal Vranckx, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Trials|November 25, 2020
Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trialGiuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, et al.
Journal of the American College of Cardiology|March 17, 2018
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesGiuseppe Gargiulo, Greta Carrara, Enrico Frigoli, et al.
The New England Journal of Medicine|September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Pageof 11